Clinical implementation of an oncology ‐specific family health history risk assessment tool

Conclusions65  % of patients attending breast cancer clinics in this study are at-risk for hereditary conditions based on current guidelines. Using a patient-facing risk assessment platform enhances the ability to identify these patients systematically and with widespread acceptability and recognized value by p atients. As only a third of at-risk participants received referrals for genetic counseling, further understanding barriers to referral is needed to optimize hereditary risk assessment in oncology practices.Trial RegistrationNIH Clinical Trials registry,NCT04639934. Registered Nov 23, 2020 -- Retrospectively registered.
Source: Hereditary Cancer in Clinical Practice - Category: Cancer & Oncology Source Type: research